Department of Pathology, University of Washington, Seattle, Washington, United States of America.
PLoS Genet. 2009 Dec;5(12):e1000751. doi: 10.1371/journal.pgen.1000751. Epub 2009 Dec 4.
In mammals, dosage compensation is achieved by doubling expression of X-linked genes in both sexes, together with X inactivation in females. Up-regulation of the active X chromosome may be controlled by DNA sequence-based and/or epigenetic mechanisms that double the X output potentially in response to autosomal factor(s). To determine whether X expression is adjusted depending on ploidy, we used expression arrays to compare X-linked and autosomal gene expression in human triploid cells. While the average X:autosome expression ratio was about 1 in normal diploid cells, this ratio was lower (0.81-0.84) in triploid cells with one active X and higher (1.32-1.4) in triploid cells with two active X's. Thus, overall X-linked gene expression in triploid cells does not strictly respond to an autosomal factor, nor is it adjusted to achieve a perfect balance. The unbalanced X:autosome expression ratios that we observed could contribute to the abnormal phenotypes associated with triploidy. Absolute autosomal expression levels per gene copy were similar in triploid versus diploid cells, indicating no apparent global effect on autosomal expression. In triploid cells with two active X's our data support a basic doubling of X-linked gene expression. However, in triploid cells with a single active X, X-linked gene expression is adjusted upward presumably by an epigenetic mechanism that senses the ratio between the number of active X chromosomes and autosomal sets. Such a mechanism may act on a subset of genes whose expression dosage in relation to autosomal expression may be critical. Indeed, we found that there was a range of individual X-linked gene expression in relation to ploidy and that a small subset ( approximately 7%) of genes had expression levels apparently proportional to the number of autosomal sets.
在哺乳动物中,通过在两性中均双倍表达 X 连锁基因,并在雌性中使 X 染色体失活,从而实现剂量补偿。活性 X 染色体的上调可能受到基于 DNA 序列和/或表观遗传机制的控制,这些机制可能会根据常染色体因子的情况将 X 染色体的输出加倍。为了确定 X 表达是否根据倍性进行调整,我们使用表达谱芯片比较了人三倍体细胞中的 X 连锁和常染色体基因表达。虽然在正常二倍体细胞中,X:常染色体表达比约为 1,但在具有一个活性 X 的三倍体细胞中,该比值较低(0.81-0.84),在具有两个活性 X 的三倍体细胞中,该比值较高(1.32-1.4)。因此,三倍体细胞中的总体 X 连锁基因表达并不严格响应常染色体因子,也不会进行调整以达到完美平衡。我们观察到的不平衡的 X:常染色体表达比可能导致与三倍体相关的异常表型。每个基因拷贝的绝对常染色体表达水平在三倍体与二倍体细胞中相似,表明对常染色体表达没有明显的全局影响。在具有两个活性 X 的三倍体细胞中,我们的数据支持 X 连锁基因表达的基本加倍。然而,在具有单个活性 X 的三倍体细胞中,X 连锁基因表达向上调整,推测是通过一种感知活性 X 染色体数量与常染色体组数之间比例的表观遗传机制。这种机制可能作用于一组基因,这些基因的表达剂量与常染色体表达相关可能是关键的。事实上,我们发现存在与倍性相关的个体 X 连锁基因表达范围,并且一小部分(约 7%)基因的表达水平显然与常染色体组数成正比。